The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series

Carrigan, Neil; Dysch, Leon; Šalkovskis, Paul M.

doi:10.1017/s135246581700056x

Cited by 8 publications

(6 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mansourzadeh et al also showed that acupressure reduces anxiety [17]. The results of Dehghan Mehr et al and Ganak et al are also consistent with our results [18,19]. Howeevr, Vali et al's study showed that acupressure does not reduce preoperative anxiety [20].…”

Section: Resultssupporting

confidence: 90%

See 1 more Smart Citation

Effect of Acupressure on Stress and Anxiety of Patients with Multiple Sclerosis: A Sham-controlled Randomized Clinical Trial

Nahayati

Vagharseyyedin

Bahrami‐Taghanaki

et al. 2020

cmja

View full text Add to dashboard Cite

Objective: Stress and anxiety are common in patients with Multiple Sclerosis (MS). These complications exacerbate the symptoms of MS. This study aims to evaluate the effect of acupressure on stress and anxiety of MS patients. Methods: In this randomized clinical trial, participants were 106 MS Patients referred to Multiple Sclerosis Society in Mashhad, Iran. After signing an informed consent form, they completed a demographic form and stress, and the Depression Anxiety Stress Scale - 42 items (DASS-42). Then, they were randomly assigned into intervention and sham groups by tossing a coin. Participants in the intervention group were asked apply a pressure on the Shenmen and Yin Tang acupoints for one month (once per day for 15 minutes), while the sham group applied pressure 2.5 cm below the Shenmen acupoint and 3 cm above the Yin Tang acupoint. Participants in each group were then completed the DASS-42 again one hour after the final session. Data were analyzed using chi-square test, Kolmogorov-Smirnov test, independent t-test, and Paired t-test. Results: In the intervention and sham groups, there was no statistically significant difference between the mean pre-test scores of stress (34.73±5.80 vs. 33.06±6.42) and anxiety (27.09±6.99 vs. 25.31±6.88), and neither between the mean post-test scores of stress (29.20±6.21 vs. 33.73±9.44) and anxiety (22.79±5.68 vs. 25.21±6.72) (P>0.05). However, comparison of DASS-42 scores between groups showed that the mean scores of stress and anxiety in the intervention group were significantly lower than in the sham group (P< 0.05). Conclusion: It seems that acupressure can be used along with other therapeutic and pharmacological interventions to reduce stress and anxiety in patients with MS.

show abstract

Section: Resultssupporting

confidence: 90%

“…In Iran, the prevalence of stress and anxiety is 44.8% and 39.1%m respectively [13]. Stress and anxiety aggravate the symptoms of MS and reduce the quality of life of these patients [15,16,19,20]. People with MS usually do not use anti-stress and anti-anxiety medications due to side effects and financial costs [21,22].…”

Section: Introductionmentioning

confidence: 99%

Effect of Acupressure on Stress and Anxiety of Patients with Multiple Sclerosis: A Sham-controlled Randomized Clinical Trial

Nahayati

Vagharseyyedin

Bahrami‐Taghanaki

et al. 2020

cmja

View full text Add to dashboard Cite

show abstract

“…If, as is possible, health anxiety is to some extent driving distress and disability experienced, then it is possible that treatment that seeks to reduce such anxiety may be helpful. This study has been replicated and, in a consecutive single case series, health anxiety was substantially reduced in four out of five patients with RRMS (Carrigan et al, 2016). We have since sought to replicate this work in patients with Parkinson's disease, where both cognitive and physical impairment was evident, obtaining similar results in terms of the perception of cognitive impairment (Fixter et al, 2016).…”

Section: Long-term Conditionsmentioning

confidence: 67%

Extending Cognitive-Behavioural Theory and Therapy to Medically Unexplained Symptoms and Long-Term Physical Conditions: A Hybrid Transdiagnostic/Problem Specific Approach

et al. 2016

Self Cite

View full text Add to dashboard Cite

Medically unexplained symptoms (MUS) are not only common and distressing, but are also typically poorly managed in general medical settings. Those suffering from these problems tend to incur significantly higher health costs than the general population. There are many effective treatments for different MUS; these are almost entirely based on cognitive-behavioural approaches. However, the wide range of treatment protocols tend to be 'syndrome specific'. As such, they do not generalise well in terms of training and application, making them expensive and difficult to disseminate, suggesting the desirability of developing a transdiagnostic approach. The general basis of such a CBT grounded transdiagnostic approach is considered, and the particular need to incorporate cognitive elements of both anxiety or health anxiety (threat) and depression (loss) is highlighted. Key empirically grounded and evidence-based processes (both specific and general) previously identified as underpinning the maintenance of MUS are delineated. The way in which these can be combined in a transdiagnostic model that accounts for most MUS presentations is presented and linked to a formulation-driven transdiagnostic treatment strategy, which is described. However, the need to take more syndrome-specific issues into account in treatment is identified, suggesting that the optimum treatment may be a hybrid transdiagnostic/specific approach with formulation, shared understanding, belief change strategies, and behavioural experiments at its heart. The generalisation of such approaches to psychological problems occurring in the context of 'long-term conditions' is identified as a further important development that is now within reach.

show abstract

“…In emotional disorders, neuroticism has been considered a key etiology mechanism shared by all emotional disorders [ 20 ]. Other mechanisms identified have been rumination, suppression, anxiety sensitivity, and misappraisal [ 21 ], frequently reported in PwMS [ 22 ]. These mechanisms can increase or maintain persistent negative emotions and may affect physical and psychological functioning.…”

Section: Introductionmentioning

confidence: 99%

Transdiagnostic treatment of emotional disorders in people with multiple sclerosis: randomized controlled trial

et al. 2020

View full text Add to dashboard Cite

Background Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. MS is significantly associated with a high rate of psychological, behavioral, and emotional consequences. Despite the frequent mental disorders, high rate of psychological comorbidities, and emotional problems in people with MS (PwMS), these conditions are often underdiagnosed and undertreated. This study aimed to examine the efficacy of a group format of the unified protocol for the transdiagnostic treatment of emotional disorders in adult PwMS associated with an emotional disorder. Methods Seventy adult PwMS were randomized using an internet-based computer system to either the unified protocol (n = 35) or treatment as usual condition. The assessment protocol included semi-structured clinical interviews and self-reports evaluating diagnostic criteria, depression, anxiety and worry symptoms, emotional dysregulation, and affectivity. Results The parametric test of analysis of covariance, followed the intent to treat analyses, revealed the unified protocol significantly changed depression symptoms (Cohen’s d = 1.9), anxiety symptoms (Cohen’s d = 2.16), worry symptoms (Cohen’s d = 1.27), emotion dysregulation (Cohen’s d = 0.44), positive affect (Cohen’s d = 1.51), and negative affect (Cohen’s d = 1.89) compared with the control group. The unified protocol also significantly improved outcome scores at the end of treatment relative to baseline (p < .001). Conclusion The findings support that the unified protocol could be an additional efficient psychological treatment for PwMS. Trial registration IRCT, number: IRCT20190711044173N1. Registered 31october 2019, https://en.irct.ir/user/trial/40779/view.

show abstract

The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series

Abstract: Given the high rates of HA in MS patients and its impact on QoL, this case series suggests that a brief CBT intervention could significantly improve patients' wellbeing.

Cited by 8 publications

References 63 publications

Effect of Acupressure on Stress and Anxiety of Patients with Multiple Sclerosis: A Sham-controlled Randomized Clinical Trial

Effect of Acupressure on Stress and Anxiety of Patients with Multiple Sclerosis: A Sham-controlled Randomized Clinical Trial

Extending Cognitive-Behavioural Theory and Therapy to Medically Unexplained Symptoms and Long-Term Physical Conditions: A Hybrid Transdiagnostic/Problem Specific Approach

Transdiagnostic treatment of emotional disorders in people with multiple sclerosis: randomized controlled trial

Contact Info

Product

Resources

About